Synedica vs Alluvi Retatrutide — 7 critical differences.

Synedica vs Alluvi Retatrutide is a comparison that’s becoming increasingly common as both brands grow their presence in the UK research peptide market. They’re priced within pennies of each other at headline level — Synedica at £190 and Alluvi at £189.99 — which makes the comparison less about price and more about what you actually get for essentially the same money.

This guide compares Synedica vs Alluvi Retatrutide on documentation, pricing mechanics, product range, brand transparency, and the practical factors that genuinely affect your purchasing experience. We supply Synedica Retatrutide and are transparent about that throughout. General research compound information is available through the MHRA.

Synedica vs Alluvi Retatrutide — fact 1: pricing mechanics

The Synedica vs Alluvi Retatrutide pricing comparison is unusual in the research peptide market because headline prices are nearly identical — £190 versus £189.99 for the 40mg pen. The genuine difference is in how each brand handles discounting.

Synedica operates at a flat £190 with no discount codes — the price you see is the price you pay, with a batch-specific COA included automatically. Alluvi offers two publicly advertised discount codes: ALLUVI10 for 10% off (bringing the effective price to approximately £171) and RD20 for 20% off (approximately £152). Wholesale rates are also referenced for orders of five or more units.

This means Alluvi can be meaningfully cheaper after applying discount codes — a genuine price advantage for anyone who finds and applies them. The Synedica vs Alluvi Retatrutide price comparison, once discounts are factored in, favours Alluvi on pure cost, provided the code works and the COA documentation standard matches.

Synedica vs Alluvi Retatrutide — fact 2: COA documentation

This is where the Synedica vs Alluvi Retatrutide comparison becomes most practically significant. Synedica includes a batch-specific Certificate of Analysis with every single order automatically — it arrives alongside the product without any additional steps, requests, or follow-up needed from the buyer.

Alluvi Healthcare references COA availability and third-party lab testing across its sites, with purity documentation described as available on request. Whether this means the COA arrives automatically with the product, or needs to be specifically requested before or after the purchase, depends on which Alluvi-affiliated site you order from and how their specific fulfilment process handles documentation.

The practical difference here is straightforward: with Synedica, you know the COA will be in your hands when the product arrives. With Alluvi, confirming this before ordering — rather than assuming — is worth the additional step. A COA that exists somewhere in a supplier’s system but doesn’t reach the buyer before they’ve committed is genuinely less useful than one that arrives automatically.

Synedica vs Alluvi Retatrutide — fact 3: product range

One notable difference in the Synedica vs Alluvi Retatrutide comparison is product range breadth. Synedica specialises specifically in retatrutide — it’s the brand’s core and primary product, supported by extensive educational content about the compound, its interactions, and its research applications.

Alluvi Healthcare offers a broader product catalogue including tirzepatide (in 20mg and 40mg formats), BPC-157, NAD+, and other research compounds alongside retatrutide. Whether this broader range is an advantage depends entirely on your needs — if you’re sourcing multiple compounds, a single supplier simplifies logistics. If you’re focused specifically on retatrutide and want a supplier whose entire reputation rests on that single compound, a specialist may offer more depth.

Synedica vs Alluvi Retatrutide — fact 4: multi-site presence

This is perhaps the most notable structural difference in the Synedica vs Alluvi Retatrutide landscape. Synedica operates through a single, clearly identifiable platform — mymetabolism.co.uk — with one set of pricing, policies, and support channels.

Alluvi Healthcare has a considerably more distributed online presence. At the time of writing, the brand appears across multiple affiliated domains including alluvihealthcare.uk.com, alluviihealthcare.uk, alluvihealthuk.co.uk, alluviofficial.com, alluviretatrutide40mg.uk, and alluvihealthcarecentre.com, among others. Each site appears to sell Alluvi products but may have different pricing, promotional offers, or purchasing terms.

This multi-site model isn’t inherently negative — it can reflect broader distribution and availability. But it does create a practical question for buyers: which is the “official” Alluvi site, and do all sites offer the same product quality, COA documentation, and customer support? For the Synedica vs Alluvi Retatrutide decision, this difference in brand architecture matters because it affects how easy it is to know exactly who you’re buying from and who to contact if something isn’t right.

Synedica vs Alluvi Retatrutide — fact 5: the tirzepatide factor

Alluvi’s tirzepatide offerings add a dimension to the Synedica vs Alluvi Retatrutide comparison that’s worth addressing separately. Tirzepatide is the active compound in Mounjaro — a licensed medicine with established clinical trial data, regulatory approval, and a defined legal framework for prescription and dispensing.

A research peptide supplier offering branded tirzepatide pens alongside retatrutide creates a specific question around how the products are positioned and whether the tirzepatide is being supplied under the same research-use framing as the retatrutide. This is a regulatory nuance that’s worth understanding for anyone comparing suppliers — particularly regarding how each brand handles compliance language and product positioning for a compound that exists in both the approved-medicine and research-compound markets simultaneously.

Synedica vs Alluvi Retatrutide — fact 6: support and education

Synedica is backed by an extensive library of educational content — interaction guides, comparison articles, practical research information, and clinical data summaries. This content exists to support informed decision-making rather than simply drive sales, and it’s part of why the Synedica brand has established strong organic search visibility for retatrutide-related queries across the UK and internationally.

Alluvi Healthcare provides product-focused content across its various sites, with FAQ sections, product descriptions, and some educational material. The volume and depth of supporting educational content is less extensive than Synedica’s library, though Alluvi has published some direct comparison content of its own. Customer support is referenced as available, with Trustpilot reviews cited as evidence of responsiveness.

The Synedica vs Alluvi Retatrutide support comparison isn’t about whether support exists — both brands reference it — but about depth and accessibility. A brand that invests in comprehensive educational content signals a longer-term commitment to its market and its customers than one that focuses primarily on product listings and pricing.

Synedica vs Alluvi Retatrutide — fact 7: how to choose

The honest Synedica vs Alluvi Retatrutide framework:

• Choose Synedica if: automatic COA with every order, a single transparent price with no discount code hunting, a single identifiable platform with 24/7 support, and specialist focus on retatrutide with comprehensive educational content are your priorities.
• Choose Alluvi if: you want to source retatrutide and tirzepatide from the same supplier, the discount codes represent meaningful savings for your budget, and you’ve verified COA provision and support access on the specific Alluvi site you’re ordering from.
• Regardless: confirm COA documentation, verify the specific site’s policies, check delivery and cold-chain handling, and never rely on brand name alone without checking the fundamentals on the actual site you’re purchasing from.

For our VLS comparison, read Synedica vs VLS Retatrutide. Explore our Synedica Retatrutide product page, or read patient reviews.